Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05783843 · ClinicalTrials.gov registry record · NA
Comparison of Text and Pictorial Waterpipe Tobacco Warnings Among Young Adults
A NA study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- NA
- Development phase
- 1,215
- Enrollment target
NCT05783843: Completed NA study, sponsored by Wake Forest University Health Sciences.
NCT05783843 is a NA study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 1,215 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (13% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05783843, a NA study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,215 participants
- Enrollment target
Study Summary
The purpose of this study is to whether exposure to waterpipe tobacco warnings reduce young adults' intentions to smoke waterpipe in the future.
Primary Outcome
The primary outcome is intention to smoke tobacco in a waterpipe within the next year, measured by averaging three items to create a composite score (adapted from research on cigarette smoking). The primary outcome will be measured after the exposure to waterpipe packages. Score ranges from 1-5 with higher score indicating greater intention to smoke hookah. 1. How interested are you in smoking hookah in the next year? 2. How likely are you to smoke hookah in the next year? 3. How much do you pl
Interventions
- BEHAVIORAL Pictorial Warnings
- BEHAVIORAL Text Warnings
- BEHAVIORAL No Warnings (Control)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,215 participants |
| Start Date | 2023-03-09 |
| Est. Completion | 2023-04-07 |
| Phase | NA |
What the finished NCT05783843 record still lists
NCT05783843 is an interventional study that assigns participants to a tested intervention. Its 1,215 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (13% lower).
The record links to 0 conditions, and to 3 interventions - of which Pictorial Warnings is the first listed.
NCT05783843 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05783843 about?
NCT05783843 is a clinical study titled "Comparison of Text and Pictorial Waterpipe Tobacco Warnings Among Young Adults". The purpose of this study is to whether exposure to waterpipe tobacco warnings reduce young adults' intentions to smoke waterpipe in the future.
What is the current status of trial NCT05783843?
This trial is currently completed. It is a NA study. The enrollment target is 1,215 participants. The study started on 2023-03-09. Estimated completion is 2023-04-07.
What interventions are being tested in trial NCT05783843?
The interventions under investigation include: Pictorial Warnings (BEHAVIORAL), Text Warnings (BEHAVIORAL), No Warnings (Control) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05783843?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05783843's enrollment target sits among peer trials
1,215 83rd of 2000 higher than 1,918 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05827016 · 1,216 participants · Phase 3
A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma
- NCT06143956 · 1,217 participants · Phase 2
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- NCT06921785 · 1,220 participants · Phase 3
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
- NCT04267848 · 1,210 participants · Phase 3
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI